Integrity Management Program Compliance Assurance

Pipeline and facility permit holders are expected to anticipate, prevent, mitigate and manage the risks associated with construction, operations and decommissioning of pipelines and facilities. A tool for managing this is the permit holders' Integrity Management Program (IMP). This documented program provides a systematic approach for assuring asset integrity throughout the full life cycle of the asset. An IMP specifies the practices that should be used by a permit holder, owner and/or operator to ensure public safety, environmental protection and operational reliability. An IMP is an integral part of an overarching management system, such as a Safety and Loss Management System (SLMS).

Pipeline IMPs

IMPs for pipelines have been a regulatory requirement since 1999. As per Section 7 of the Pipeline Regulation, every pipeline permit holder must have developed and implemented an IMP prior to operating a pipeline. The Commission's Compliance Assurance Protocol (IMPP) is available to assist permit holders in developing pipeline IMPs.

An IMP self-assessment questionnaire is available for pipeline operators to appraise the scope and effectiveness of their IMPs.

Pipeline IMP Compliance Assurance Annual Report

For an overview of the compliance assurance process, a summary and analysis of audit results, and insight into operators’ performance and compliance, read the latest annual report.

Facility IMPs

The Liquefied Natural Gas (LNG) Facility Regulation and the Drilling and Production Regulation require facility permit holders to develop and implement facility IMPs. This allows for the permit holder to assess and manage risks over the entire life cycle of a facility, to reduce incidents, and to ensure safe, environmentally responsible and reliable operation of the asset. The Commission has developed a new Compliance Assurance Protocol - Integrity Management Program for Facilities (IMPF). 

An IMPF self-assessment questionnaire is available for facility operators to appraise the scope and effectiveness of their IMPFs.

Please contact with any questions.